欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PL/H/0487/006
药品名称Ramipril + Amlodipine + Hydrochlorothiazide Adamed
活性成分
    • amlodipine 10.0 mg
    • hydrochlorothiazide 25.0 mg
    • ramipril 10.0 mg
剂型Capsule, hard
上市许可持有人Adamed Pharma S.A. Pieńków, ul. M. Adamkiewicza 6A 05-152 Czosnów Poland
参考成员国 - 产品名称Poland (PL)
Ramipril + Amlodipine + Hydrochlorothiazide Adamed
互认成员国 - 产品名称
    • Germany (DE)
      Ramipril + Amlodipine + Hydrochlorothiazide Adamed 10 mg + 10 mg + 25 mg Hartkapseln
    • Austria (AT)
      Ramipril/Amlodipin/HCT Genericon 10 mg/10 mg/25 mg Hartkapseln
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Bulgaria (BG)
      Ramipril + Amlodipine + Hydrochlorothiazide Adamed
    • Croatia (HR)
      Pinmirol Plus 10 mg/10 mg/25 mg tvrde kapsule
许可日期2019/01/18
最近更新日期2024/07/31
药物ATC编码
    • C09BX03 ramipril, amlodipine and hydrochlorothiazide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase